Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Pulmonary Regurgitation clinical trials
1 of 5 indexed Pulmonary Regurgitation trials are currently recruiting.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Pulmonary Regurgitation: 5 US clinical trials tracked, 1 recruiting.
Pulmonary Regurgitation is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Edwards Lifesciences, running 2 of these trials.
Enrollment posture brief
Registry condition pulmonary-regurgitation
OPEN 1 | RECR 20% | LATE 0 | EARLY 0 | RANK #3391 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)
Pulmonary Regurgitation lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Pulmonary Regurgitation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Pulmonary Regurgitation is recruiting below its size-band peers.
1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Pulmonary Regurgitation research.
Edwards Lifesciences accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.
-
Most Pulmonary Regurgitation trials plan to enrol fewer than 100 people.
Median target enrolment is 86 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.
-
Pulmonary Regurgitation research is mostly interventional.
4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
VenusP-Valve Pivotal Study (PROTEUS STUDY)
Venus MedTech (HangZhou)
NCT06010563
ALTERRA Post-Approval Study
Edwards Lifesciences
NCT05378386
Harmony TPV Post-Approval Study
Medtronic Cardiovascular
NCT05077774
The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study
Medtronic Heart Valves
NCT02979587
ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent
Edwards Lifesciences
NCT03130777
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Pulmonary Regurgitation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Pulmonary Regurgitation trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Pulmonary Regurgitation page
5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Pulmonary Regurgitation trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Edwards Lifesciences sponsors the most Pulmonary Regurgitation trials on record, review their full trial history before evaluating a specific study. See Edwards Lifesciences's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pulmonary Regurgitation condition card totals 5 registered trials; most-linked intervention Harmony TPV System; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.